Company Overview and News

1
Accenture's Q3 2018 Results: A Company That Is Firing On All Cylinders

2018-07-05 seekingalpha
The company is firing on all cylinders and investors should expect for more of the same in the quarters ahead.
ITT ACN INOTF

101
The R.I.P. Portfolio: Q2 2018 Update

2018-07-04 seekingalpha
The portfolio has underperformed its benchmark so far in 2018, with General Electric being a significant contributor, but it is properly positioned to benefit from several major trends.
FB TWX UAA MET KEY BAC TWTR AAPL ACN INOTF CAH INTC BAC GEC GE C ITT BHGE SYF TWC UA BHI TGT GNE

0
'You can’t undo that damage': How safe is your health data?

2018-06-30 theage.com.au
For the next three months, Australians have the chance to stop the government creating a digital medical health record with their information.
ITT INOTF

0
'You can’t undo that damage': How safe is your health data?

2018-06-30 smh.com.au
For the next three months, Australians have the chance to stop the government creating a digital medical health record with their information.
ITT INOTF

0
Internet of Things Inc. Closes Acquisition of Weather Telematics Inc.

2018-06-04 globenewswire
TORONTO and OTTAWA, June 04, 2018 (GLOBE NEWSWIRE) -- Internet of Things Inc. (TSX VENTURE:ITT) (OTC:INOTF) (FRANKFURT:71T) (“IoT Inc.” or the “Company”) a strategic investor and operator of emerging technology companies with innovative IoT, AI and Blockchain solutions, has completed the previously announced acquisition of Weather Telematics Inc. (“WTX Inc.” or “Weather Telematics”). WTX Inc. is a data science company offering real-time advanced artificial intelligence (AI) based predictive road condition weather analytics for safer, connected and autonomous transportation.
INOTF

0
Internet of Things Inc. to Acquire Weather Telematics Inc.

2018-05-14 globenewswire
TORONTO and OTTAWA, May 14, 2018 (GLOBE NEWSWIRE) -- Internet of Things Inc. (TSX VENTURE:ITT) (OTC:INOTF) (FRANKFURT:71T) (“IoT Inc.” or the “Company”) a strategic investor in growth-oriented companies with innovative IoT, AI and Blockchain solutions, is pleased to announce that it has entered into a letter agreement to acquire Weather Telematics Inc. (“WTX Inc.” or “Weather Telematics”) a data science company offering real-time advanced artificial intelligence (AI) based predictive road condition weather analytics for safer, connected and autonomous transportation.
INOTF

0
Internet of Things Inc. Hires James Sutcliffe as President & COO

2018-05-11 globenewswire
TORONTO, May 11, 2018 (GLOBE NEWSWIRE) -- Internet of Things Inc. (TSX VENTURE:ITT) (OTC:INOTF) (FRANKFURT:71T) (“IoT Inc.” or “the Company”) an IoT software and solutions provider targeting the Industrial IoT market, is pleased to announce the appointment of James Sutcliffe as President & COO. Mr. Sutcliffe will oversee operations, investee companies and work with management to expand its strategic plan to acquire and operate growth ready technology companies.
INOTF

0
BRIEF-Internet Of Things Received TSX Venture Approval For Joint Venture Agreement With New Hope Group

2018-04-13 reuters
* INTERNET OF THINGS INC. RECEIVED TSX VENTURE APPROVAL FOR JOINT VENTURE AGREEMENT WITH NEW HOPE GROUP Source text for Eikon: Further company coverage:
ITT INOTF

394
The R.I.P. Portfolio: Q1 2018 Update

2018-04-03 seekingalpha
This real-money portfolio was first introduced to the Seeking Alpha community in December 2015 and it outperformed its benchmark in each of the last two years.
BAC GEC GE C ITT TWX MET TWC DWDP BAC TWTR AAPL ACN INOTF GNE INTC

12
Everyone is a Closet Technician

2018-03-29 thereformedbroker
Everyone is a closet technician. Everyone. And in a panic or a market correction, this truism is even more, um, truistic.
ITT INOTF MS

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...